BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37227732)

  • 1. HDAC8 as an emerging target in drug discovery with special emphasis on medicinal chemistry.
    Rajaraman S; Balakrishnan R; Deshmukh D; Ganorkar A; Biswas S; Pulya S; Ghosh B
    Future Med Chem; 2023 May; 15(10):885-908. PubMed ID: 37227732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological Role of HDAC8: Cancer and Beyond.
    Kim JY; Cho H; Yoo J; Kim GW; Jeon YH; Lee SW; Kwon SH
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview.
    Banerjee S; Adhikari N; Amin SA; Jha T
    Eur J Med Chem; 2019 Feb; 164():214-240. PubMed ID: 30594678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of HDAC8 inhibitors: Non-hydroxamates as anticancer agents.
    Amin SA; Adhikari N; Jha T
    Pharmacol Res; 2018 May; 131():128-142. PubMed ID: 29514055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic structure-based pharmacophore model development: a new and effective addition in the histone deacetylase 8 (HDAC8) inhibitor discovery.
    Thangapandian S; John S; Lee Y; Kim S; Lee KW
    Int J Mol Sci; 2011; 12(12):9440-62. PubMed ID: 22272142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and nonselective HDAC8 inhibitors: a therapeutic patent review.
    Adhikari N; Amin SA; Jha T
    Pharm Pat Anal; 2018 Nov; 7(6):259-276. PubMed ID: 30632447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors.
    Zhao C; Zang J; Ding Q; Inks ES; Xu W; Chou CJ; Zhang Y
    Eur J Med Chem; 2018 Apr; 150():282-291. PubMed ID: 29533873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse classes of HDAC8 inhibitors: in search of molecular fingerprints that regulate activity.
    Amin SA; Adhikari N; Jha T
    Future Med Chem; 2018 Jul; 10(13):1589-1602. PubMed ID: 29953251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC8: a multifaceted target for therapeutic interventions.
    Chakrabarti A; Oehme I; Witt O; Oliveira G; Sippl W; Romier C; Pierce RJ; Jung M
    Trends Pharmacol Sci; 2015 Jul; 36(7):481-92. PubMed ID: 26013035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.
    Suzuki T; Muto N; Bando M; Itoh Y; Masaki A; Ri M; Ota Y; Nakagawa H; Iida S; Shirahige K; Miyata N
    ChemMedChem; 2014 Mar; 9(3):657-64. PubMed ID: 24403121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8.
    Stoddard SV; May XA; Rivas F; Dodson K; Vijayan S; Adhika S; Parker K; Watkins DL
    Mol Inform; 2019 Mar; 38(3):e1800080. PubMed ID: 30369061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity.
    Darwish S; Ghazy E; Heimburg T; Herp D; Zeyen P; Salem-Altintas R; Ridinger J; Robaa D; Schmidtkunz K; Erdmann F; Schmidt M; Romier C; Jung M; Oehme I; Sippl W
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
    Marek M; Shaik TB; Heimburg T; Chakrabarti A; Lancelot J; Ramos-Morales E; Da Veiga C; Kalinin D; Melesina J; Robaa D; Schmidtkunz K; Suzuki T; Holl R; Ennifar E; Pierce RJ; Jung M; Sippl W; Romier C
    J Med Chem; 2018 Nov; 61(22):10000-10016. PubMed ID: 30347148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Histone Deacetylase 8 Inhibitor through Drug Screenings Based on Machine Learning.
    Nurani A; Yamashita Y; Taki Y; Takada Y; Itoh Y; Suzuki T
    Chem Pharm Bull (Tokyo); 2024; 72(2):173-178. PubMed ID: 38296560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors.
    Fontana A; Cursaro I; Carullo G; Gemma S; Butini S; Campiani G
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compromised structure and function of HDAC8 mutants identified in Cornelia de Lange Syndrome spectrum disorders.
    Decroos C; Bowman CM; Moser JA; Christianson KE; Deardorff MA; Christianson DW
    ACS Chem Biol; 2014 Sep; 9(9):2157-64. PubMed ID: 25075551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand and structure based pharmacophore modeling to facilitate novel histone deacetylase 8 inhibitor design.
    Thangapandian S; John S; Sakkiah S; Lee KW
    Eur J Med Chem; 2010 Oct; 45(10):4409-17. PubMed ID: 20656379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity.
    Heimburg T; Kolbinger FR; Zeyen P; Ghazy E; Herp D; Schmidtkunz K; Melesina J; Shaik TB; Erdmann F; Schmidt M; Romier C; Robaa D; Witt O; Oehme I; Jung M; Sippl W
    J Med Chem; 2017 Dec; 60(24):10188-10204. PubMed ID: 29190092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC).
    Chotitumnavee J; Yamashita Y; Takahashi Y; Takada Y; Iida T; Oba M; Itoh Y; Suzuki T
    Chem Commun (Camb); 2022 Apr; 58(29):4635-4638. PubMed ID: 35311871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.